Company: MYGN
Filing Date: 2025-01-15
Form Type: 8-K
Source: 0000899923-25-000002
Chunk: 2

Company: MYRIAD GENETICS INC
Filing Date: 2025-01-15
Form: 8-K
Item: Item 2.02
Chunk 2
---
 Company may not be able maintain effective disclosure controls and procedures and internal control over financial reporting; risks related to current and future investigations, claims or lawsuits, including derivative claims, product or professional liability claims, and risks related to the amount of the Company's insurance coverage limits and scope of insurance coverage with respect thereto; and other factors discussed under the heading “ Risk Factors” contained in Item 1A of the Company’s Annual Report on Form 10-K filed with the U. S. Securities and Exchange Commission (SEC) on February 28, 2024 as updated in the Company's Quarterly Reports on Form 10-Q filed with the SEC on May 8, 2024 and November 8, 2024, as well as any further updates to those risk factors filed from time to time in the Company’s future filings with the SEC. The Company is not under any obligation, and it expressly disclaims any obligation, to update or alter any forward-looking statements, whether as a result of new information, future events or otherwise except as required by law.

ITEM 9.01 Financial Statements and Exhibits.